Total raised
$800K
Last: Seed 2023-02
Stage
Seed
Founded
2020
Headcount
2
HQ
Yeruham
Sector
Health Tech & Life Sciences
About
3R Pharma is developing high-end and complex cannabinoid-based pharmaceutical products to address chronic ocular diseases for patients around the world. These patent-pending cannabinoid-based medicines provide a novel treatment option for various conditions that are currently insufficiently addressed. The company's R&D unit, based in Israel, is licensed to conduct scientific and clinical research on cannabinoid formulations by the Ministry of Health IMC.
Funding history · 2 rounds · $800K total
2023-02
Seed
Undisclosed
2021-10
Pre-Seed
$800K
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
medical-cannabistherapeuticspharmaceuticalschronic-patientspatent-pendingcannabisophthalmologypatientstreatments